Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human herpesvirus type 6 and multiple sclerosis.

Duncan Clark1

  • 1Department of Virology, Royal Free and University College Medical School, London, UK. d.clark@rfc.ucl.ac.uk

Herpes : the Journal of the IHMF
|August 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth.

Nature communications·2026
Same author

Developmental relations between internalizing symptoms and negative urgency during middle adolescence.

Development and psychopathology·2026
Same author

Developmental variation in dopamine neurobiology, neurocognitive functioning, and impulsivity shape substance use trajectories in youth.

bioRxiv : the preprint server for biology·2025
Same author

Development of a Novel Loop Mediated Isothermal Amplification Assay (LAMP) for the Rapid Detection of Epizootic Haemorrhagic Disease Virus.

Viruses·2021
Same author

Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children.

JAMA neurology·2021
Same author

Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP).

Journal of virological methods·2020

The cause of multiple sclerosis (MS) remains unknown, but research suggests a potential link with human herpesvirus-6 (HHV-6). Current evidence is contradictory, necessitating further rigorous studies to confirm causality.

Area of Science:

  • Neuroimmunology
  • Virology
  • Epidemiology

Background:

  • The etiology of multiple sclerosis (MS) is multifactorial, likely involving genetic and environmental factors.
  • Geographical distribution and epidemic patterns suggest a potential infectious component in MS.
  • Herpesviruses, including human herpesvirus-6 (HHV-6), are investigated due to their neurotropic and latent properties.

Purpose of the Study:

  • To review the evidence linking human herpesvirus-6 (HHV-6) to the etiology of multiple sclerosis (MS).
  • To assess the validity and contradictions in studies investigating HHV-6 and MS.
  • To provide recommendations for future research and therapeutic evaluations.

Main Methods:

  • Analysis of case-control studies comparing HHV-6 detection in brain tissue, cerebrospinal fluid (CSF), and peripheral blood mononuclear cells (PBMCs) of MS patients and controls.

Related Experiment Videos

  • Evaluation of polymerase chain reaction (PCR) positivity for HHV-6 in relation to MS diagnosis.
  • Review of recommendations from the International Herpes Management Forum (IHMF) for future studies.

    • Main Results:

    • HHV-6 was detected in a significant proportion of both MS patients and healthy individuals, indicating PCR positivity alone is insufficient to establish causality.
    • Studies investigating the association between HHV-6 and MS have yielded contradictory findings.
    • The International Herpes Management Forum (IHMF) highlights the need for validated, sensitive methods and independent analyses in future research.

    Conclusions:

    • The causal role of HHV-6 in multiple sclerosis (MS) remains unproven due to conflicting evidence.
    • Future research must employ rigorous methodologies, including masked sample analysis, to clarify the association.
    • Therapeutic trials evaluating drugs with activity against HHV-6 may be considered if further evidence emerges.